Shiseido Company, Limited

TSE:4911 Stock Report

Market Cap: JP¥1.1t

Shiseido Company Valuation

Is 4911 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 4911 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 4911 (¥2730.5) is trading below our estimate of fair value (¥4010.11)

Significantly Below Fair Value: 4911 is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 4911?

Key metric: As 4911 is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 4911. This is calculated by dividing 4911's market cap by their current revenue.
What is 4911's PS Ratio?
PS Ratio1.1x
SalesJP¥973.38b
Market CapJP¥1.09t

Price to Sales Ratio vs Peers

How does 4911's PS Ratio compare to its peers?

The above table shows the PS ratio for 4911 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.9x
4527 Rohto PharmaceuticalLtd
2.3x9.7%JP¥635.7b
1.8x3.1%JP¥2.9t
4967 Kobayashi Pharmaceutical
2.4x3.7%JP¥399.8b
4922 KOSÉ
1.2x4.4%JP¥381.3b
4911 Shiseido Company
1.1x5.6%JP¥1.1t

Price-To-Sales vs Peers: 4911 is good value based on its Price-To-Sales Ratio (1.1x) compared to the peer average (1.9x).


Price to Sales Ratio vs Industry

How does 4911's PS Ratio compare vs other companies in the JP Personal Products Industry?

1 CompanyPrice / SalesEstimated GrowthMarket Cap
4920 Nippon Shikizai
0.1xn/aUS$16.39m
No more companies available in this PS range
4911 1.1xIndustry Avg. 1.2xNo. of Companies5PS00.81.62.43.24+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 4911 is good value based on its Price-To-Sales Ratio (1.1x) compared to the JP Personal Products industry average (1.2x).


Price to Sales Ratio vs Fair Ratio

What is 4911's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

4911 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio1.1x
Fair PS Ratio2.6x

Price-To-Sales vs Fair Ratio: 4911 is good value based on its Price-To-Sales Ratio (1.1x) compared to the estimated Fair Price-To-Sales Ratio (2.6x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 4911 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentJP¥2,739.50
JP¥3,646.43
+33.1%
12.7%JP¥4,600.00JP¥3,000.00n/a14
Nov ’25JP¥3,158.00
JP¥4,181.43
+32.4%
19.2%JP¥5,600.00JP¥3,000.00n/a14
Oct ’25JP¥3,848.00
JP¥4,181.43
+8.7%
19.2%JP¥5,600.00JP¥3,000.00n/a14
Sep ’25JP¥3,261.00
JP¥4,760.77
+46.0%
17.6%JP¥6,200.00JP¥3,160.00n/a13
Aug ’25JP¥4,625.00
JP¥5,203.25
+12.5%
15.6%JP¥6,200.00JP¥3,600.00n/a12
Jul ’25JP¥4,610.00
JP¥5,203.25
+12.9%
15.8%JP¥6,200.00JP¥3,600.00n/a12
Jun ’25JP¥4,971.00
JP¥5,221.73
+5.0%
16.6%JP¥6,200.00JP¥3,500.00n/a11
May ’25JP¥4,354.00
JP¥4,783.64
+9.9%
18.9%JP¥5,850.00JP¥3,320.00n/a11
Apr ’25JP¥4,174.00
JP¥4,783.64
+14.6%
18.9%JP¥5,850.00JP¥3,320.00n/a11
Mar ’25JP¥4,148.00
JP¥4,847.27
+16.9%
18.3%JP¥5,850.00JP¥3,320.00n/a11
Feb ’25JP¥4,096.00
JP¥5,396.00
+31.7%
23.3%JP¥7,600.00JP¥3,500.00n/a13
Jan ’25JP¥4,252.00
JP¥5,504.00
+29.4%
22.6%JP¥7,600.00JP¥3,500.00n/a12
Dec ’24JP¥3,940.00
JP¥6,134.14
+55.7%
23.2%JP¥8,200.00JP¥3,500.00n/a14
Nov ’24JP¥4,889.00
JP¥7,229.33
+47.9%
14.4%JP¥9,000.00JP¥5,000.00JP¥3,158.0015
Oct ’24JP¥5,250.00
JP¥7,286.00
+38.8%
13.8%JP¥9,000.00JP¥5,000.00JP¥3,848.0015
Sep ’24JP¥5,937.00
JP¥7,286.00
+22.7%
13.8%JP¥9,000.00JP¥5,000.00JP¥3,261.0015
Aug ’24JP¥6,109.00
JP¥7,280.00
+19.2%
12.7%JP¥9,000.00JP¥5,100.00JP¥4,625.0015
Jul ’24JP¥6,493.00
JP¥7,253.33
+11.7%
12.6%JP¥9,000.00JP¥5,100.00JP¥4,610.0015
Jun ’24JP¥6,251.00
JP¥7,143.75
+14.3%
11.1%JP¥8,080.00JP¥5,100.00JP¥4,971.0016
May ’24JP¥6,922.00
JP¥6,966.88
+0.6%
10.1%JP¥8,080.00JP¥5,100.00JP¥4,354.0016
Apr ’24JP¥6,181.00
JP¥6,966.88
+12.7%
10.1%JP¥8,080.00JP¥5,100.00JP¥4,174.0016
Mar ’24JP¥6,236.00
JP¥6,976.88
+11.9%
13.8%JP¥8,690.00JP¥4,700.00JP¥4,148.0016
Feb ’24JP¥6,640.00
JP¥6,808.13
+2.5%
14.9%JP¥8,690.00JP¥4,700.00JP¥4,096.0016
Jan ’24JP¥6,471.00
JP¥6,430.63
-0.6%
14.9%JP¥8,400.00JP¥4,700.00JP¥4,252.0016
Dec ’23JP¥6,034.00
JP¥6,217.06
+3.0%
15.1%JP¥8,400.00JP¥4,700.00JP¥3,940.0017
Nov ’23JP¥5,185.00
JP¥6,028.89
+16.3%
15.9%JP¥8,400.00JP¥4,700.00JP¥4,889.0018

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies